Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. by Jamjoom, AAB et al.
120 Jamjoom AAB, et al. J Neurol Neurosurg Psychiatry 2018;89:120–126. doi:10.1136/jnnp-2017-316415
ReseaRch papeR
Prospective, multicentre study of external ventricular 
drainage-related infections in the UK and Ireland
aimun a B Jamjoom,1 alexis J Joannides,2 Michael Tin-chung poon,1 aswin chari,3 
Malik Zaben,4 Mutwakil a h abdulla,2,4 Joy Roach,5 Laurence J Glancz,6 anna solth,7 
John Duddy,8 paul M Brennan,1 Roger Bayston,9 Diederik O Bulters,10 
conor L Mallucci,10 Michael D Jenkinson,11,12 William p Gray,4 Jothy Kandasamy,1 
peter J hutchinson,2 angelos G Kolias,2 aminul I ahmed,5 on behalf of the British 
Neurosurgical Trainee Research collaborative
Neurosurgery
To cite: Jamjoom aaB, 
Joannides aJ, poon MT-c, 
et al. J Neurol Neurosurg 
Psychiatry 2018;89:120–126.
For numbered affiliations see 
end of article.
Correspondence to
Mr aimun a B Jamjoom, 
Department of clinical 
Neuroscience, Western 
General hospital, crewe Road 
south, edinburgh, eh42XU;  
aabjamjoom@ gmail. com
Received 10 May 2017
Revised 16 september 2017
accepted 9 October 2017
published Online First 
25 October 2017
 ► http:// dx. doi. org/ 10. 1136/ 
jnnp- 2017- 317105
AbsTrACT
Objectives external ventricular drain (eVD) insertion 
is a common neurosurgical procedure. eVD-related 
infection (eRI) is a major complication that can lead 
to morbidity and mortality. In this study, we aimed to 
establish a national eRI rate in the UK and Ireland and 
determine key factors influencing the infection risk.
Methods a prospective multicentre cohort study of eVD 
insertions in 21 neurosurgical units was performed over 
6 months. The primary outcome measure was 30-day 
eRI. a cox regression model was used for multivariate 
analysis to calculate hR.
results a total of 495 eVD catheters were inserted into 
452 patients with eVDs remaining in situ for 4700 days 
(median 8 days; IQR 4–13). Of the catheters inserted, 
188 (38%) were antibiotic-impregnated, 161 (32.5%) 
were plain and 146 (29.5%) were silver-bearing. a total 
of 46 eRIs occurred giving an infection risk of 9.3%. 
cox regression analysis demonstrated that factors 
independently associated with increased infection 
risk included duration of eVD placement for ≥8 days 
(hR=2.47 (1.12–5.45); p=0.03), regular sampling (daily 
sampling (hR=4.73 (1.28–17.42), p=0.02) and alternate 
day sampling (hR=5.28 (2.25–12.38); p<0.01). There 
was no association between catheter type or tunnelling 
distance and eRI.
Conclusions In the UK and Ireland, the eRI rate was 
9.3% during the study period. The study demonstrated 
that eVDs left in situ for ≥8 days and those sampled 
more frequently were associated with a higher risk of 
infection. Importantly, the study showed no significant 
difference in eRI risk between different catheter types.
INTrOduCTION
The insertion of an external ventricular drain (EVD) 
is one of the the most common neurosurgical proce-
dures. It was first described by Claude-Nicholas 
Le Cat in 1744 when he punctured the ventricle 
and left a wick in situ for congenital hydroceph-
alus.1 Since then, the procedure has seen significant 
refinement in its technique, an expansion of its indi-
cations and technological advances in the materials 
used for drainage and insertion.2 In the last two 
decades, EVD research has focused on improving 
the accuracy of ventricular access and infection 
control. EVD-related infection (ERI) is a significant 
complication that can lead to increased morbidity 
and healthcare costs.3 ERI has a reported rate in the 
literature between 1% and 45%.4 This wide vari-
ation is driven by differing definitions of ERI and 
study methodology. A range of factors are reported 
to be associated with increased ERI risk including 
duration of drainage, cerebrospinal fluid (CSF) 
leak, frequency of sampling and underlying aeti-
ology.4–8 Efforts to reduce ERI risk have included 
the introduction of EVD care bundles, the use of 
perioperative or continuous prophylactic antibiotics 
and the development of antimicrobial-impregnated 
catheters.5 9–11 Observational studies of ERI rates 
have been primarily retrospective and those which 
collected data prospectively have been restricted 
to single neurosurgical units (NSUs).4 12–16 Studies 
with these limitations have inherent practice and 
selection biases, do not accurately reflect current 
national practice for generating health economic 
models nor do they lend themselves to gener-
ating a baseline against which future multicentre 
randomised trials can be designed and adequately 
powered. Using prospectively collected data from 
multiple NSUs, we aimed to determine the national 
infection rate, assess the incorporation of current 
evidence into clinical practice and identify param-
eters associated with increased infection rates that 
can be interrogated in future clinical studies and be 
used to target preventative measures.
MATerIAls ANd MeThOds
A prospective, multicentre observational study 
of EVD management and infection rates was 
conducted across 21 NSUs in the UK and Ireland. 
Primary data collection took place over 6 months 
between November 2014 and May 2015 followed 
by 30-day follow-up. The inclusion criteria were 
any tunnelled EVD catheter inserted in a patient 
of any age without evidence of pre-existing CSF 
infection. The study protocol was approved by the 
Society of British Neurological Surgeons (SBNS) 
Academic Committee and conducted by the 
British Neurosurgical Trainee Research Collabo-
rative (BNTRC).17 Strengthening the Reporting 
of Observational Studies in Epidemiology 
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(STROBE) checklist was used to guide the preparation of this 
manuscript.18
data collection and outcome measures
The BNTRC is a network of neurosurgical trainees in the UK 
and Ireland who conduct multicentre collaborative research 
with the support of the academic committee of the Society of 
British Neurological Surgeons.19 20 Within each NSU, a trainee 
lead coordinated local patient identification and data collec-
tion working closely with a team of collaborators, including a 
Consultant lead. Data were entered to the Outcome Registry 
Intervention and Operation Network (ORION) based at the 
University of Cambridge. ORION is a secure database, which 
complies with the Department of Health Information Gover-
nance policy and meets data security standards of the Infor-
mation Governance Toolkit of the Health and Social Care 
Information Centre. The study protocol was approved by the 
audit and clinical governance committee of each participating 
hospital.
A range of demographic and operative parameters were 
captured including age, sex, underlying aetiology, primary 
surgeon grade, type of catheter (plain, antibiotic-impregnated 
or silver-bearing), length of tunnelling and frequency of subse-
quent CSF sampling protocol (daily, alternate days, 1–2 times 
per week, no sampling and unknown). The primary outcome 
was ERI within 30 days. A pragmatic definition of ERI was 
used: evidence of positive CSF culture (and/or gram stain) or 
clinical suspicion of ERI by managing team due to CSF pleo-
cytosis, elevated serum inflammatory markers and clinical 
signs including fever, meningism and altered conscious level.21 
Secondary outcome measures included: mortality in the NSU, 
functional status at discharge using the modified Rankin Score 
(mRS) and permanent CSF diversion at 30 days.
statistical analysis
The statistical approach follows the principles outlined in the 
study protocol.17 In the univariate analyses, χ² test or Fisher’s 
exact test was used to compare clinical variables between infected 
and non-infected cases and outcomes between different types of 
catheters. The duration of prophylactic antibiotic therapy and 
time to infection was compared using the Kruskal-Wallis test. 
In the multivariate analyses of ERIs, prespecified independent 
variables were entered which included type of catheter, length 
of tunnelling, CSF sampling frequency and dichotomised 
duration of EVD use around the median. These were chosen 
because of their known or hypothesised association with ERI. 
To examine the rate of ERIs, HRs for ERI were calculated using 
Cox regression model adjusted for age, sex, type of catheter, 
length of tunnelling, CSF sampling frequency and dichotomised 
duration of EVD use. The time-at-risk period was from date of 
EVD insertion to ERI, death or 30 days after EVD insertion. To 
examine factors associated with ERIs a multiple logistic regres-
sion model using the prespecified independent variables was 
used. As a sensitivity analysis to test whether NSU influenced the 
odds of infection within 30 days of EVD insertion, a multilevel 
mixed effect logistic regression was performed using hospitals as 
clusters. This model was compared with a single-level multiple 
logistic regression model using the likelihood ratio test. We used 
STATA V.13.0 (StataCorp) for conducting statistical tests and 
generating graphical outputs. A p value of <0.05 denoted statis-
tical significance.
resulTs
demographic and operative data
During the 6-month period, a total of 495 EVD catheters were 
inserted in 452 patients. The follow-up was 12 308 days (median 
30 days; IQR 23–30). The median age at time of insertion was 
54 years and 261 (52.7%) catheters were inserted in female 
patients. Hydrocephalus secondary to a neurovascular aetiology 
(64.9%) was the the most common indication for EVD inser-
tion followed by tumours (17.8%) and trauma (7.1%). The base-
line demographic characteristics of the cohort are presented in 
table 1.
The majority (98.6%) of EVDs were inserted in the operating 
theatre and the remainder (1.4%) were inserted in the intensive 
care unit. In most cases (85.3%) prophylactic systemic anti-
biotics were given at induction. A small number (3.2%) had 
prolonged systemic antibiotic prophylaxis with the remaining 
groups either already on antibiotics (3.8%) or receiving no 
systemic antimicrobial prophylaxis (7.7%). Neurosurgical 
trainees were the primary surgeon in 424 (85.7%) EVD proce-
dures with 66% of the total being inserted by senior trainees. 
Of the catheters inserted, 188 (38%) were antibiotic-impreg-
nated, 161 (32.5%) were plain and 146 (29.5%) were silver-
bearing catheters. EVDs remained in situ for a total of 4700 
days (median of 8 days (IQR 4–13)). Table 2 presents opera-
tive data regarding the EVD procedures.
Table 1 Demographic data for 495 EVD catheters
Patient characteristics No. %
Age
  Mean (SD) 51.8 (19.2) –
  Median (IQR) 54 (41–67) –
Age groups
  0–17 37 7.4
  18–29 34 6.8
  30–39 45 9.1
  40–49 78 15.8
  50–59 113 22.8
  60–69 103 20.8
  70–79 66 13.3
  80–89 15 3.0
  90+ 4 1.0
Gender
  Female 261 52.7
  Male 234 47.3
Pathology
  Congenital, IIH and NPH 12 2.4
  Shunt dysfunction 19 3.8
  Neurovascular 321 64.9
  Other 20 4.0
  Trauma 35 7.1
  Tumour 88 17.8
Preoperative ASA status
  1 117 23.6
  2 108 21.8
  3 111 22.4
  4 131 26.5
  5 28 5.7
ASA, American Society of Anaesthesiologists; EVD, external ventricular drain; IIH, 
idiopathic intracranial hypertension; NPH, normal pressure hydrocephalus.
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Infection outcome
Infection rate
Forty-six ERIs were observed during the follow-up period. The 
overall risk of infection was 9.3% (n=46/495) within 30 days. 
One ERI had a missing date of infection. Of the remaining 45 
ERIs, six occurred after EVD removal. Therefore, the rate of 
ERI while an EVD was in place was 0.8% per day. The median 
time to infection was 9 days (IQR 5–15). For 25 cases of ERI, 
pathogens were isolated with a total of 29 organisms. The most 
common organisms were coagulase negative staphylococcus 
(n=10, 34.5%), followed by Staphylococcus aureus (n=6, 
20.7%) and Enterococcus spp. (n=3, 10.3%). Table 3 includes 
the frequency of all isolated microbiological organisms.
The median length of treatment with antibiotics was 10 days 
(IQR 7–14). A comparison of infected versus uninfected cases 
using the Χ2 test demonstrated that a significantly higher 
percentage of infected cases had a catheter in situ for ≥8 days 
(77.8%) compared with uninfected cases (47.3%) (p<0.01). 
Similarly, a significantly higher percentage of infected cases had 
their EVD sampled more frequently (daily or on alternate days) 
compared with uninfected cases (p<0.01). Conversely, there was 
no significant difference between infected and uninfected cases 
with regard to the different catheter types (p=0.31), length of 
tunnelling (p=0.71) or the likelihood of permanent CSF diver-
sion at 30 days (p=0.91). Table 4 provides comparison between 
the infected and uninfected cases.
Comparison between EVD catheter types infection outcome
A Χ2 test for homogeneity showed there was no significant 
difference between the distribution of catheter types across 
the cohort age groups, gender and underlying pathology. A 
comparison of the infection rate according to catheter types 
showed that silver-bearing catheters had the highest infection 
rate (13.7%), compared with plain (7.5%) and antibiotic-im-
pregnated catheters (7.4%), but this did not reach statistical 
significance (p=0.09). The median time to infection was 
longest for the antibiotic-impregnated catheters (11 days) 
followed by plain catheters (8 days) and then silver-bearing 
(7 days). Infections on a background of antibiotic-impreg-
nated catheters received antibiotic treatment for a median of 
14 days, silver-bearing catheters received a median of 10 days’ 
therapy and plain catheters received 7.5 days. Table 5 provides 
a summary of clinical and infection variation between the cath-
eter subtypes.
Table 2 Operative data for 495 EVD catheters
Operative characteristics No. %
Length of tunnelling
  0–5 cm 119 24.0
  5–10 cm 359 72.5
  >10 cm 17 3.4
Postoperative CT head scan
  No 100 20.2
  Yes 395 79.8
CSF sampling frequency
  No sampling 129 26.1
  1–2 times per week 234 47.3
  Alternate days 24 4.9
  Daily 7 1.4
  Unknown 101 20.4
Catheter type
  Plain 161 32.5
  Antibiotic-impregnated 188 38
  Silver-bearing 146 29.5
Primary surgeon
  Intern/Foundation doctor 5 1.0
  Junior neurosurgery trainee 97 19.6
  Senior neurosurgery trainee 327 66.1
  Consultant/Attending 66 13.3
CSF, cerebrospinal fluid; EVD, external ventricular drain. 
Table 3 List of organisms cultured from CSF samples
Cultured organisms No. %
Coagulase-negative staphylococcus* 10 34.5
Staphylococcus aureus 6 20.7
Enterococcus spp. 3 10.3
Enterobacter spp. 2 6.9
Klebsiella pneumoniae 2 6.9
Morganella morganii 1 3.4
Escherichia coli 1 3.4
Klebsiella sp. 1 3.4
Pseudomonas aeruginosa 1 3.4
Corynebacterium sp. 1 3.4
Streptococcus sp. 1 3.4
*Three cases due to Staphylococcus epidermidis.
CSF, cerebrospinal fluid.
Table 4 Comparison between infected and uninfected catheters
Infection within 30 days
p ValueNo (%) Yes (%)
Catheter type
  Plain 149 (92.5) 12 (7.5) 0.314
  Antibiotic-impregnated 174 (92.6) 14 (7.4)
  Silver-bearing 126 (86.3) 20 (13.7)
CSF sampling frequency
  No sampling 129 (100) 0 (0) <0.01
  1–2 times per week 211 (90.2) 23 (9.8)
  Alternate days 15 (62.5) 9 (26.5)
  Daily 3 (42.9) 4 (57.1)
  Unknown 91 (90.1) 10 (9.9)
Length of tunnelling
  0–5 cm 106 (89.1) 13 (10.9) 0.71
  5–10 cm 328 (91.4) 31 (8.6)
  >10 cm 15 (88.2) 2 (11.8)
Primary surgeon
  Intern/Foundation doctor 4 (80.0) 1 (20.0) 0.25
  Junior neurosurgery trainee 87 (89.7) 10 (10.3)
  Senior neurosurgery trainee 294 (89.9) 33 (10.1)
  Consultant 64 (97.0) 2 (3.0)
Duration of EVD use*
  0–7 days 236 (95.9) 10 (4.1) <0.01
  8+days 212 (85.8) 35 (14.2)
CSF diversion
  Permanent CSF diversion 71 (91.0) 7 (9.0) 0.91
  No permanent diversion 378 (90.6) 39 (9.4)
Comparisons made using Χ2 test.
*Two cases excluded as no valid exit date.
CSF, cerebrospinal fluid; EVD, external ventricular drain. 
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Clinical variables associated with infection
There was a significant increase in risk of infection for both 
daily and alternate day sampling regimens compared with cath-
eters that were sampled 1–2 times per week. Similarly, cathe-
ters left in situ for>8 days had a higher risk of ERI compared 
with those removed at 7 days or less (OR=2.54 (95% CI 1.14 
to 5.7); p=0.02). There was no association between the under-
lying pathology and the risk of infection in univariate analysis 
(p=0.76). Catheters tunnelled>5 cm had an ERI OR of 0.75 
((95% CI 0.3 to 1.45); p=0.29) compared with those with 
shorter tunnelling. Nelson-Aalen cumulative hazard estimate 
curves of catheter type, EVD duration and length of tunnel-
ling are shown in figure 1. To determine whether NSU had an 
effect on ERI, a likelihood ratio test, comparing a multilevel 
mixed effects logistic regression using hospitals as clusters, was 
performed; ERI rate did not significantly vary between hospitals 
(p=0.16). A Cox regression model adjusted for age, sex, type 
of catheter, length of tunnelling, CSF sampling frequency and 
duration of EVD use based on 441 EVDs where time-at-risk was 
available identified a higher rate of infection for catheters kept 
in situ for 8 days or longer (HR=2.47 (95% CI 1.12 to 5.45); 
p=0.03). Using a similar analysis, there was no significant differ-
ence in ERI risk between catheter types (table 6).
Paediatric subanalysis
Among the 37 catheters inserted into patients aged<18, there 
were three infections giving the paediatric cohort an infection 
rate of 8.1%. The distribution of pathologies between adult 
and paediatric cases is shown in table 7. There was a significant 
(p<0.01) difference in the pathological aetiology necessitating 
an EVD insertion between the different age groups. Similarly, 
there was a significant difference of the catheter types inserted 
into the two cohorts. Particularly, antibiotic-impregnated cathe-
ters were preferred in the paediatric cohort constituting 62.2% 
of catheters compared with only 36% of catheters in adults. 
Importantly, exclusion of the paediatric subcohort did not cause 
a change in the observed association trends in the Cox regres-
sion analysis. Catheter drainage>8 days and sampling frequency 
(daily and alternate days) remained significantly associated with 
increased ERI risk.
Mortality and functional outcome
There were 114 (25.2%) deaths observed within 30 days after 
EVD insertion in the 452 patients recruited in our study (table 5). 
Of the surviving patients, 164 (48.5%) had a good functional 
outcome (mRS 0–2) and 174 (51.5%) had a poor outcome (mRS 
3–4).
dIsCussION
Using a network of neurosurgical trainees and the BNTRC 
infrastructure, we were able to capture data on a national level 
and provide the largest prospective multicentre observational 
study of EVD management and infection rate in the literature. 
We confirmed 46 ERIs from 495 catheters giving an infection 
risk of 9.3% (or 9.8 ERIs per 1000 catheter days). This falls 
Table 5 Comparison of clinical and infection parameters between catheter subtypes
Plain
(n=161) Antibiotic-impregnated (n=188)
silver-bearing
(n=146)
p ValueNo. % No. % No. %
30-day infection
  No 149 92.6 174 92.6 126 86.3 0.09
  Yes 12 7.5 14 7.4 20 13.7
Time to infection (median)
8 (1–29) – 11 (2–29) – 7 (1–39) – 0.19
Length of antibiotic therapy for ERI (median)
7.5 (1–28) – 14 (1–87) – 10 (1–37) – 0.23
Cultured microorganisms
  Coagulase-negative staphylococcus (p) 4 36.3 2 25.0 4 40.0 –
  Staphylococcus aureus (p) 3 27.3 2 25.0 1 10.0 –
  Enterococcus spp. (p) 1 9.1 2 25.0 – – –
  Enterobacter spp. (n) – – 1 12.5 1 10.0 –
  Klebsiella pneumoniae (n) 1 9.1 – – 1 10.0 –
  Morganella morganii (n) – – – – 1 10.0 –
  Escherichia coli (n) 1 9.1 – – – – –
  Klebsiella (n) 1 9.1 – – – – –
  Pseudomonas aeruginosa (n) – – – – 1 10.0 –
  Corynebacterium (p) – – 1 12.5 – – –
  Streptococcus spp. (p) – – – – 1 10.0 –
30-day mortality*
  No 100 70.4 145 81.0 93 71.0 0.05
  Yes 42 29.6 34 19.0 38 29.0
30-day mRS*
  Good (mRS 0–2) 50 35.2 79 44.1 35 26.7 0.01
  Poor (mRS 3–5) 50 35.2 66 36.9 58 44.3
  Death 42 29.6 34 19.0 38 29.0
*30-day mortality and 30-day mRS based on 452 non-duplicate patients; (p)=gram stain positive; (n)=gram stain negative.
ERI, external ventricular drain-related infection; mRS, modified Rankin Score.
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within the wide range of quoted infection risk within the litera-
ture; however, direct comparison is limited due to the differing 
definitions of ERIs used. We chose a pragmatic definition which 
included culture-positive CSF or other features of ERI (CSF 
pleocytosis, raised inflammatory markers, clinical features of 
meningitis) that prompted treatment. This definition is used in 
a range of studies including a previously published randomised 
trial assessing the effectiveness of silver-bearing catheters.21 A 
meta-analysis by Ramanan and colleagues looked at ERIs and 
found a total of 35 observational studies reported an overall 
infection rate of 11.4 ERIs per 1000 catheter days.4 Within their 
study, the authors found several definitions of infection rates 
used by the 35 studies and the pragmatic definition used in our 
study was the second most used definition (seven studies). The 
meta-analysis of these seven studies found a total of 17 ERIs per 
1000 catheter days (95% CI 10 to 24.1). This value was double 
our findings of 9.8 ERIs per 1000 catheter days. This compar-
ison, despite its limitations, reflects that the UK and Ireland’s 
ERI rate is consistent with the literature and may be lower than 
studies with an equivalent ERI definition.
One of our key findings was an increased ERI rate with a 
longer duration of EVD placement. Catheters in situ for≥8 days 
were associated with a greater than twofold increase in rate of 
developing an ERI compared with those in place for 7 days or 
less. The literature has conflicting evidence on the relationship 
between the length of EVD placement and ERI. Some studies 
have shown no association with duration of EVD placement 
and ERI,22 while others corroborated our findings.7 8 More-
over, some authors have recommended routine replacement of 
EVDs,23 while others argue against this.6 Wong and colleagues 
interrogated this question in a small RCT where they compared 
Figure 1 Nelson-aalen cumulative hazard estimate of eVD infection 
by (a) type of eVD catheter: log-rank test of equality showed p=0.06, (B) 
catheter duration: log-rank test of equality showed p<0.01, (c) tunnelling 
length: log-rank test of equality showed p=0.41. eVD, external ventricular 
drain.
Table 6 HRs for EVD infection rate using Cox regression model
hr 95% CI p Value
Catheter type
  Plain Ref – –
  Antibiotic-impregnated 0.87 0.37 to 2.03 0.75
  Silver-bearing 1.35 0.63 to 2.88 0.44
Length of tunnelling
  0–5 cm Ref – –
  >5 cm 0.75 0.36 to 1.55 0.44
CSF sampling frequency
  1–2 times per week Ref - -
  Alternate days 5.28 2.25 to 12.38 <0.01
  Daily 4.73 1.28 to 17.42 0.02
  Unknown 1.26 0.56 to 2.82 0.58
Duration of EVD use
  0–7 days Ref - -
  ≥8 days 2.47 1.12 to 5.45 0.03
*Cox regression model adjusted for age and sex based on 441 EVDs where date of 
exit (infection, death or 30 days) was available.
CSF, cerebrospinal fluid; EVD, external ventricular drain.
Table 7 Comparison between paediatric and adult cohort pathology 
and EVD type
Paediatrics Adults p Value
Pathology <0.01
  Congenital 4 (10.8) 8 (1.8)
  Shunt dysfunction 3 (8.1) 16 (3.5)
  Neurovascular 8 (21.6) 313 (68.4)
  Other 3 (8.1) 17 (3.7)
  Trauma 5 (13.5) 30 (6.6)
  Tumour 14 (37.8) 74 (16.2)
Catheter types <0.01
  Conventional 5 (13.5) 156 (34.1)
  Antibiotic-impregnated 23 (62.2) 165 (36.0)
  Silver-bearing 9 (24.3) 137 (29.9)
EVD, external ventricular drain.
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routine EVD change (every 5 days) to no change.24 The study 
found no difference in ERIs but a trend to higher infection in 
the routine change group; the authors advised against the use 
of regular pre-emptive EVD replacement. Our data also showed 
that an increased frequency of CSF sampling was found to be 
a significant parameter associated with ERI risk. In keeping 
with this, several studies have found that patients with an ERI 
were sampled more frequently than those without an ERI.6 7 
Their statistical approaches may have been biased by the fact 
that the number of CSF samples increased with the duration of 
EVD placement. Our approach did not use absolute numbers 
of samples taken but rather the sampling frequency protocol. 
Though this approach has its benefits, we are unable to conclude 
a direct causal relationship between sampling frequency and 
ERI. When assessed in the Cox regression model, we found that 
both catheter duration and sampling frequency were associated 
with a significantly higher ERI risk. Based on the literature and 
our data, we conclude that catheters should be removed as early 
as possible and a lower frequency sampling protocol should be 
considered as this may help reduce ERI risk.
The development of antimicrobial impregnated catheters 
(both antibiotic-bearing and silver-bearing catheters) has been a 
major approach for combating ERI risk. The most commonly 
used antibiotic-impregnated catheters contain clindamycin and 
rifampicin, while the silver-bearing catheters contain silver 
nanoparticles. These catheters impede and kill bacteria with the 
goal of reducing ERI risk and several studies have attempted to 
assess their effectiveness. Despite heterogeneity, meta-analyses 
of these data have broadly pointed towards the effectiveness of 
impregnated catheters compared with plain catheters.9 10 Inter-
estingly, our study showed that despite this body of evidence, 
almost a third of catheters inserted in the UK and Ireland were 
plain catheters. Our study also failed to demonstrate a signif-
icant difference in infection risk between the three different 
catheter types after adjusting for a range of clinical variables, 
although there was a trend towards silver-bearing catheters 
having the highest ERI rate. This is in contrast to a previous 
trial that suggest silver-bearing catheters are more effective than 
plain.21 In meta-analyses, antibiotic-impregnated catheters have 
shown more pronounced reductions in ERI risk compared with 
plain catheters when compared with reductions of risk seen 
in silver versus plain catheters.9 10 This reflects evidence from 
central venous catheters that found superiority of antibiotic-im-
pregnated catheters compared with those coated with silver in 
reducing bloodstream infections.25 In the UK and Ireland, a major 
multicentre RCT (The British Antibiotic and Silver Impregnated 
Catheters for ventriculoperitoneal Shunts trial; BASICS trial) is 
currently under way aiming to assess the comparative efficacy of 
antibiotic-bearing, silver-bearing and plain catheters in reducing 
CSF infections for patients with a ventriculoperitoneal shunt.26 
The results of this trial will be of great interest to the field and 
help guide future trial designs looking at a similar question in 
EVD care. While our data do not support the routine use of anti-
biotic-bearing and silver-bearing EVD catheters to reduce ERI 
risk, it highlights an important cost implication that warrants 
further study since antibiotic-bearing and silver-bearing cathe-
ters are substantially more expensive.
In our study, the majority of cultured organisms were gram-pos-
itive (68.9%) and staphylococci were the most common agent 
(55.1%). The predominance of staphylococci mirrors other 
findings in the literature.7 8 27 Most cultured organisms from all 
three catheter types were gram-positive organisms: plain cath-
eters (63.6%), antibiotic-impregnated catheters (87.5%) and 
silver-bearing catheters (60%). These findings run counter to 
trends described in the literature of a shift towards gram-nega-
tive organisms.6 12 28 A range of explanations has been proposed 
including the impact of antimicrobial-impregnated catheters. In 
vitro investigation of silver-bearing catheters found a greater 
eradication of Staphylococcus epidermidis compared with Esch-
erichia coli.29 It is of interest that in our data the two cases of 
Enterobacter were in patients with antibiotic-impregnated and 
silver-bearing catheters. Atkinson and colleagues concluded 
that their observed increase in gram-negative organisms was 
related to the use of silver-bearing catheters; however, their 
small sample placed limitations on this conclusion.6 Prolonged 
systemic prophylactic antibiotics during drainage has also been 
implicated in a shift towards more gram-negative microorgan-
isms.28 30 In our study, only a small percentage (3.2%) of cases 
received prolonged systemic antibiotics which may, in part, 
explain the dominance of gram-positive organisms.
This study has a number of limitations. First, we were unable 
to confirm case ascertainment in individual NSUs. In part, this 
was due to the nature of rotational neurosurgical training which 
meant trainees would move units, not allowing for continuous 
data collection in some units. This may have led to an under-re-
porting of inserted EVDs which could have led to bias in the 
results. Second, our choice of ERI definition could be open 
to criticism as it places an onus on the managing clinician to 
determine the presence of ERIs in cases without a positive 
CSF culture. This may overestimate the number of ERIs in 
our cohort due to the presence of false positives. However, as 
argued above, we believe that the definition is pragmatic, holds 
relevance for day-to-day clinical practice and has been used in 
previous RCTs.21 Third, NSUs may have different protocols for 
EVD management that influence the risk of ERIs. In particular, 
a strict infection control protocol for manipulation of EVD is 
shown to be associated with a lower risk of ERIs.31 32 Local EVD 
management protocols may confound the results shown in our 
study. This confounding effect is not likely to have had a large 
impact on our results since our sensitivity analysis did not show 
a significant difference in local infection rates, but this aspect of 
EVD care should be taken into account when interpreting the 
results. Coupled to this, we did not capture data on concomi-
tant infections which may act as a confounder. Within the data, 
we also found a significant difference in mortality between cath-
eter subtypes. Though an interesting finding, our study was not 
designed to examine this question and caution should be taken 
in drawing conclusions around this observation which is at risk 
of confounders. Finally, many NSUs favour a single catheter type 
for EVD insertion. Therefore, factors specific to individual units 
which contribute to infection rate may confound the overall 
infection risk difference between the three catheter subtypes. 
While we did not demonstrate a significant difference between 
the catheter subtypes, the ERIs between the three groups allow us 
to perform adequate power calculations for future randomised 
trials.
CONClusION
This study demonstrated an ERI rate of 9.3% in 21 centres 
in the UK and Ireland with a predominance of gram-positive 
organisms. Patients with an EVD left in situ for ≥8 days and 
who underwent more frequent sampling had a higher risk of 
infection. Importantly, there was wide variation in the choice 
of catheter across the country with no significant difference in 
ERI risk between the types. These findings support the need for 
a prospective clinical trial to assess the comparative effectiveness 
of EVD catheter type on ERI risk.
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